IMMURON LIMITED
🏢 View company profile →5Patents
4Active
5Granted
40Portfolio score
Filing activity: Mar 4, 2004 → Apr 17, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8637025B2 | Composition and method for the treatment and prevention of enteric bacterial infections | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9943597B2 | Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder | Chemistry; Metallurgy | 3 | Active |
| US10117930B2 | Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder | Chemistry; Metallurgy | 1 | Active |
| US9402902B2 | Composition and method for the treatment and prevention of enteric bacterial infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US10144775B2 | Methods and compositions for the treatment and/or prophylaxis of Clostridium difficile associated disease | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.